Genetics of diabetes - Are we missing the genes or the disease?

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 726-739

  Groop, Leif ^a,b   Pociot, Flemming ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

GWAS; LADA:MODY; Type 1 diabetes; Type 2 diabetes

Indexed keywords

MICRORNA;

ARTICLE; CLINICAL RESEARCH; COPY NUMBER VARIATION; DIABETES MELLITUS; EPIGENETICS; EXERCISE; GENETIC LINKAGE; GENETIC VARIABILITY; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; SYSTEMS BIOLOGY;

GWAS; LADA:MODY; TYPE 1 DIABETES; TYPE 2 DIABETES;

DIABETES MELLITUS; EPISTASIS, GENETIC; GENE-ENVIRONMENT INTERACTION; GENES; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84888321284     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.04.002     Document Type: Article

References (164)

1. Almind K., Bjorbaek C., Vestergaard H., Hansen T., Echwald S., Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993, 342:828-832.
2. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., Lane C.R., Schaffner S.F., Bolk S., Brewer C., Tuomi T., Gaudet D., Hudson T.J., Daly M., Groop L., Lander E.S. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 2000, 26:76-80.
3. Aly T.A., Ide A., Jahromi M.M., Barker J.M., Fernando M.S., Babu S.R., Yu L., Miao D., Erlich H.A., Fain P.R., Barriga K.J., Norris J.M., Rewers M.J., Eisenbarth G.S. Extreme genetic risk for type 1A diabetes. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:14074-14079.
4. American Diabetes Association, 2011. Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl. 1), S62-9.
5. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25:25-29.
6. Bailey R., Cooper J.D., Zeitels L., Smyth D.J., Yang J.H., Walker N.M., Hypponen E., Dunger D.B., Ramos-Lopez E., Badenhoop K., Nejentsev S., Todd J.A. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007, 56:2616-2621.
7. Bakhtadze E., Cervin C., Lindholm E., Borg H., Nilsson P., Arnqvist H.J., Bolinder J., Eriksson J.W., Gudbjornsdottir S., Nystrom L., Agardh C.D., Landin-Olsson M., Sundkvist G., Groop L.C. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34years) but not in middle-aged (40-59years) diabetic patients. Diabetologia 2008, 51:2224-2232.
8. Banin P., Rimondi F., De Togni A., Cantoni S., Chiari G., Iughetti L., Salardi S., Zucchini S., Marsciani A., Suprani T., Tarchini L., Tozzola A., Xella R., Marsella M., De Sanctis V. Type 1 diabetes (T1DM) in children and adolescents of immigrated families in Emilia-Romagna (Italy). Acta Biomed. 2010, 81:35-39.
9. Baranzini S.E., Galwey N.W., Wang J., Khankhanian P., Lindberg R., Pelletier D., Wu W., Uitdehaag B.M., Kappos L., Polman C.H., Matthews P.M., Hauser S.L., Gibson R.A., Oksenberg J.R., Barnes M.R. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet. 2009, 18:2078-2090.
10. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., Julier C., Morahan G., Nerup J., Nierras C., Plagnol V., Pociot F., Schuilenburg H., Smyth D.J., Stevens H., Todd J.A., Walker N.M., Rich S.S. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 2009, 41:703-707.
11. Bennett S.T., Wilson A.J., Cucca F., Nerup J., Pociot F., McKinney P.A., Barnett A.H., Bain S.C., Todd J.A. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J. Autoimmun. 1996, 9:415-421.
12. Bergholdt R. Understanding type 1 diabetes genetics - approaches for identification of susceptibility genes in multi-factorial diseases. Dan. Med. Bull. 2009, 56:1-39.
13. Bergholdt R., Karlsen A.E., Hagedorn P.H., Aalund M., Nielsen J.H., Kruhoffer M., Orntoft T., Wang H., Wollheim C.B., Nerup J., Pociot F. Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets. Genes Immun. 2007, 8:232-238.
14. Bergholdt R., Brorsson C., Palleja A., Berchtold L.A., Floyel T., Bang-Berthelsen C.H., Frederiksen K.S., Jensen L.J., Storling J., Pociot F. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 2012.
15. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 2008, 40:695-701.
16. Bradfield J.P., Qu H.-Q., Wang K., Zhang H., Sleiman P.M., Kim C.E., Mentch F.D., Qiu H., Glessner J.T., Thomas K.A., Frackelton E.C., Chiavacci R.M., Imielinski M., Monos D.S., Pandey R., Bakay M., Grant S.F.A., Polychronakos C., Hakonarson H. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet. 2011, 7:e1002293.
17. Brasacchio D., Okabe J., Tikellis C., Balcerczyk A., George P., Baker E.K., Calkin A.C., Brownlee M., Cooper M.E., El-Osta A. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009, 58:1229-1236.
18. Broadbent H.M., Peden J.F., Lorkowski S., Goel A., Ongen H., Green F., Clarke R., Collins R., Franzosi M.G., Tognoni G., Seedorf U., Rust S., Eriksson P., Hamsten A., Farrall M., Watkins H. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum. Mol. Genet. 2008, 17:806-814.
19. Bronson P.G., Ramsay P.P., Thomson G., Barcellos L.F. Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes. Diabetes Obes. Metab. 2009, 11(Suppl 1):74-83.
20. Brorsson C., Tue Hansen N., Bergholdt R., Brunak S., Pociot F. The type 1 diabetes - HLA susceptibility interactome-identification of HLA genotype-specific disease genes for type 1 diabetes. PLoS ONE 2010, 5:e9576.
21. Burren O.S., Adlem E.C., Achuthan P., Christensen M., Coulson R.M.R., Todd J.A. T1DBase: update 2011, organization and presentation of large-scale data sets for type 1 diabetes research. Nucleic Acids Res. 2011, 39:D997-D1001.
22. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., Chen R.O., Brownstein B.H., Cobb J.P., Tschoeke S.K., Miller-Graziano C., Moldawer L.L., Mindrinos M.N., Davis R.W., Tompkins R.G., Lowry S.F. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037.
23. Cervin C., Lyssenko V., Bakhtadze E., Lindholm E., Nilsson P., Tuomi T., Cilio C.M., Groop L. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008, 57:1433-1437.
24. Chambers J.C., Elliott P., Zabaneh D., Zhang W., Li Y., Froguel P., Balding D., Scott J., Kooner J.S. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 2008, 40:716-718.
25. Chong S., Whitelaw E. Epigenetic germline inheritance. Curr. Opin. Genet. Dev. 2004, 14:692-696.
26. Clayton D.G. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet. 2009, 5:e1000540.
27. Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Pociot F., Todd J.A., Rich S.S. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005, 54:2995-3001.
28. Concannon P., Chen W.M., Julier C., Morahan G., Akolkar B., Erlich H.A., Hilner J.E., Nerup J., Nierras C., Pociot F., Todd J.A., Rich S.S. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009, 58:1018-1022.
29. Cooper J.D., Smyth D.J., Smiles A.M., Plagnol V., Walker N.M., Allen J.E., Downes K., Barrett J.C., Healy B.C., Mychaleckyj J.C., Warram J.H., Todd J.A. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat. Genet. 2008, 40:1399-1401.
30. Cooper J.D., Walker M.D., Healy B.C., Smyth D.J., Downes K., Todd J.A. Analysis of 55 autoimmune disease and type II diabets loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1. Genes Immun. 2009, 10:S95-S120. the Type 1 Diabetes Genetics Consortium.
31. Cooper J.D., Walker M.D., Smyth D.J., Downes K., Healy B.C., Todd J.A. Follow-up of 1715 SNPs from the Wellcome Trust Case Control Consortium genome-wide association study in type 1 diabetes families. Genes Immun. 2009, 10:S85-S94. the Type 1 Diabetes Genetics Consortium.
32. Cooper J.D., Howson J.M., Smyth D., Walker N.M., Stevens H., Yang J.H., She J.X., Eisenbarth G.S., Rewers M., Todd J.A., Akolkar B., Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Nierras C., Pociot F., Rich S.S. Confirmation of novel type 1 diabetes risk loci in families. Diabetologia 2012, 55:996-1000.
33. Cordell H.J., Todd J.A., Bennett S.T., Kawaguchi Y., Farrall M. Two-locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type 1 diabetes. Am. J. Hum. Genet. 1995, 57:920-934.
34. Cordell H.J., Wedig G.C., Jacobs K.B., Elston R.C. Multilocus linkage tests based on affected relative pairs. Am. J. Hum. Genet. 2000, 66:1273-1286.
35. Cortes A., Brown M. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 2011, 13:101.
36. Cox N.J., Frigge M., Nicolae D.L., Concannon P., Hanis C.L., Bell G.I., Kong A. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat. Genet. 1999, 21:213-215.
37. Cox N.J., Wapelhorst B., Morrison V.A., Johnson L., Pinchuk L., Spielman R.S., Todd J.A., Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am. J. Hum. Genet. 2001, 69:820-830.
38. Craddock N., Hurles M.E., Cardin N., Pearson R.D., Plagnol V., Robson S., Vukcevic D., Barnes C., Conrad D.F., Giannoulatou E., Holmes C., Marchini J.L., Stirrups K., Tobin M.D., Wain L.V., Yau C., Aerts J., Ahmad T., Andrews T.D., Arbury H., Attwood A., Auton A., Ball S.G., Balmforth A.J., Barrett J.C., Barroso I., Barton A., Bennett A.J., Bhaskar S., Blaszczyk K., Bowes J., Brand O.J., Braund P.S., Bredin F., Breen G., Brown M.J., Bruce I.N., Bull J., Burren O.S., Burton J., Byrnes J., Caesar S., Clee C.M., Coffey A.J., Connell J.M., Cooper J.D., Dominiczak A.F., Downes K., Drummond H.E., Dudakia D., Dunham A., Ebbs B., Eccles D., Edkins S., Edwards C., Elliot A., Emery P., Evans D.M., Evans G., Eyre S., Farmer A., Ferrier I.N., Feuk L., Fitzgerald T., Flynn E., Forbes A., Forty L., Franklyn J.A., Freathy R.M., Gibbs P., Gilbert P., Gokumen O., Gordon-Smith K., Gray E., Green E., Groves C.J., Grozeva D., Gwilliam R., Hall A., Hammond N., Hardy M., Harrison P., Hassanali N., Hebaishi H., Hines S., Hinks A., Hitman G.A., Hocking L., Howard E., Howard P., Howson J.M., Hughes D., Hunt S., Isaacs J.D., Jain M., Jewell D.P., Johnson T., Jolley J.D., Jones I.R., Jones L.A., et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010, 464:713-720.
39. Davidson B.L., McCray P.B. Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 2011, 12:329-340.
40. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., Reed P.W., Gough S.C., Jenkins S.C., Palmer S.M., et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994, 371:130-136.
41. Deeb S.S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., Laakso M., Fujimoto W., Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 1998, 20:284-287.
42. Dina C., Meyre D., Gallina S., Durand E., Korner A., Jacobson P., Carlsson L.M., Kiess W., Vatin V., Lecoeur C., Delplanque J., Vaillant E., Pattou F., Ruiz J., Weill J., Levy-Marchal C., Horber F., Potoczna N., Hercberg S., Le Stunff C., Bougneres P., Kovacs P., Marre M., Balkau B., Cauchi S., Chevre J.C., Froguel P. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 2007, 39:724-726.
43. Duggirala R., Blangero J., Almasy L., Dyer T.D., Williams K.L., Leach R.J., O'Connell P., Stern M.P. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet. 1999, 64:1127-1140.
44. Dupuis J., Langenberg C., Prokopenko I., Saxena R., Soranzo N., Jackson A.U., Wheeler E., Glazer N.L., Bouatia-Naji N., Gloyn A.L., Lindgren C.M., Magi R., Morris A.P., Randall J., Johnson T., Elliott P., Rybin D., Thorleifsson G., Steinthorsdottir V., Henneman P., Grallert H., Dehghan A., Hottenga J.J., Franklin C.S., Navarro P., Song K., Goel A., Perry J.R., Egan J.M., Lajunen T., Grarup N., Sparso T., Doney A., Voight B.F., Stringham H.M., Li M., Kanoni S., Shrader P., Cavalcanti-Proenca C., Kumari M., Qi L., Timpson N.J., Gieger C., Zabena C., Rocheleau G., Ingelsson E., An P., O'Connell J., Luan J., Elliott A., McCarroll S.A., Payne F., Roccasecca R.M., Pattou F., Sethupathy P., Ardlie K., Ariyurek Y., Balkau B., Barter P., Beilby J.P., Ben-Shlomo Y., Benediktsson R., Bennett A.J., Bergmann S., Bochud M., Boerwinkle E., Bonnefond A., Bonnycastle L.L., Borch-Johnsen K., Bottcher Y., Brunner E., Bumpstead S.J., Charpentier G., Chen Y.D., Chines P., Clarke R., Coin L.J., Cooper M.N., Cornelis M., Crawford G., Crisponi L., Day I.N., de Geus E.J., Delplanque J., Dina C., Erdos M.R., Fedson A.C., Fischer-Rosinsky A., Forouhi N.G., Fox C.S., Frants R., Franzosi M.G., Galan P., Goodarzi M.O., Graessler J., Groves C.J., Grundy S., Gwilliam R., Gyllensten U., Hadjadj S., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 2010, 42:105-116.
45. Enattah N.S., Jensen T.G., Nielsen M., Lewinski R., Kuokkanen M., Rasinpera H., El-Shanti H., Seo J.K., Alifrangis M., Khalil I.F., Natah A., Ali A., Natah S., Comas D., Mehdi S.Q., Groop L., Vestergaard E.M., Imtiaz F., Rashed M.S., Meyer B., Troelsen J., Peltonen L. Independent introduction of two lactase-persistence alleles into human populations reflects different history of adaptation to milk culture. Am. J. Hum. Genet. 2008, 82:57-72.
46. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., Mychaleckyj J.C., Todd J.A., Bonella P., Fear A.L., Lavant E., Louey A., Moonsamy P. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
47. Evans D.M., Marchini J., Morris A.P., Cardon L.R. Two-stage two-locus models in genome-wide association. PLoS Genet. 2006, 2:e157.
48. Fernandez-Valverde S.L., Taft R.J., Mattick J.S. MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications. Diabetes 2011, 60:1825-1831.
49. Filippi C.M., von Herrath M.G. Viral trigger for type 1 diabetes: pros and cons. Diabetes 2008, 57:2863-2871.
50. Fourlanos S., Varney M.D., Tait B.D., Morahan G., Honeyman M.C., Colman P.G., Harrison L.C. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008, 31:1546-1549.
51. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., Perry J.R., Elliott K.S., Lango H., Rayner N.W., Shields B., Harries L.W., Barrett J.C., Ellard S., Groves C.J., Knight B., Patch A.M., Ness A.R., Ebrahim S., Lawlor D.A., Ring S.M., Ben-Shlomo Y., Jarvelin M.R., Sovio U., Bennett A.J., Melzer D., Ferrucci L., Loos R.J., Barroso I., Wareham N.J., Karpe F., Owen K.R., Cardon L.R., Walker M., Hitman G.A., Palmer C.N., Doney A.S., Morris A.D., Smith G.D., Hattersley A.T., McCarthy M.I. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
52. Froguel P., Vaxillaire M., Sun F., Velho G., Zouali H., Butel M.O., Lesage S., Vionnet N., Clement K., Fougerousse F., et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992, 356:162-164.
53. Fung E.Y., Smyth D.J., Howson J.M., Cooper J.D., Walker N.M., Stevens H., Wicker L.S., Todd J.A. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun. 2009, 10:188-191.
54. Gale E.A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002, 51:3353-3361.
55. Gillespie K.M., Bain S.C., Barnett A.H., Bingley P.J., Christie M.R., Gill G.V., Gale E.A. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2004, 364:1699-1700.
56. Glans F., Elgzyri T., Shaat N., Lindholm E., Apelqvist J., Groop L. Immigrants from the Middle-East have a different form of Type 2 diabetes compared with Swedish patients. Diabet. Med. 2008, 25:303-307.
57. Gonzalez-Perez A., Gayan J., Marin J., Galan J.J., Saez M.E., Real L.M., Antunez C., Ruiz A. Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson's disease. Neurogenetics 2009, 10:173-181.
58. Gouda H.N., Sagoo G.S., Harding A.H., Yates J., Sandhu M.S., Higgins J.P. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am. J. Epidemiol. 2010, 171:645-655.
59. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., Styrkarsdottir U., Magnusson K.P., Walters G.B., Palsdottir E., Jonsdottir T., Gudmundsdottir T., Gylfason A., Saemundsdottir J., Wilensky R.L., Reilly M.P., Rader D.J., Bagger Y., Christiansen C., Gudnason V., Sigurdsson G., Thorsteinsdottir U., Gulcher J.R., Kong A., Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 2006, 38:320-323.
60. Grant S.F., Qu H.Q., Bradfield J.P., Marchand L., Kim C.E., Glessner J.T., Grabs R., Taback S.P., Frackelton E.C., Eckert A.W., Annaiah K., Lawson M.L., Otieno F.G., Santa E., Shaner J.L., Smith R.M., Skraban R., Imielinski M., Chiavacci R.M., Grundmeier R.W., Stanley C.A., Kirsch S.E., Waggott D., Paterson A.D., Monos D.S., Polychronakos C., Hakonarson H. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes 2009, 58:290-295.
61. Groop L., Forsblom C., Lehtovirta M., Tuomi T., Karanko S., Nissen M., Ehrnstrom B.O., Forsen B., Isomaa B., Snickars B., Taskinen M.R. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 1996, 45:1585-1593.
62. Groop L., Tuomi T., Rowley M., Zimmet P., Mackay I.R. Latent autoimmune diabetes in adults (LADA) - more than a name. Diabetologia 2006, 49:1996-1998.
63. Group S.f.D.i.Y.S. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for diabetes in youth study. Pediatrics 2006, 118:1510-1518.
64. Group T.W.G.f.t.S.f.D.i.Y.S. Incidence of diabetes in youth in the United States. JAMA, J. Am. Med. Assoc. 2007, 297:2716-2724.
65. Gudmundsson J., Sulem P., Steinthorsdottir V., Bergthorsson J.T., Thorleifsson G., Manolescu A., Rafnar T., Gudbjartsson D., Agnarsson B.A., Baker A., Sigurdsson A., Benediktsdottir K.R., Jakobsdottir M., Blondal T., Stacey S.N., Helgason A., Gunnarsdottir S., Olafsdottir A., Kristinsson K.T., Birgisdottir B., Ghosh S., Thorlacius S., Magnusdottir D., Stefansdottir G., Kristjansson K., Bagger Y., Wilensky R.L., Reilly M.P., Morris A.D., Kimber C.H., Adeyemo A., Chen Y., Zhou J., So W.Y., Tong P.C., Ng M.C., Hansen T., Andersen G., Borch-Johnsen K., Jorgensen T., Tres A., Fuertes F., Ruiz-Echarri M., Asin L., Saez B., van Boven E., Klaver S., Swinkels D.W., Aben K.K., Graif T., Cashy J., Suarez B.K., van Vierssen Trip O., Frigge M.L., Ober C., Hofker M.H., Wijmenga C., Christiansen C., Rader D.J., Palmer C.N., Rotimi C., Chan J.C., Pedersen O., Sigurdsson G., Benediktsson R., Jonsson E., Einarsson G.V., Mayordomo J.I., Catalona W.J., Kiemeney L.A., Barkardottir R.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Stefansson K. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet. 2007, 39:977-983.
66. Hakonarson H., Grant S.F., Bradfield J.P., Marchand L., Kim C.E., Glessner J.T., Grabs R., Casalunovo T., Taback S.P., Frackelton E.C., Lawson M.L., Robinson L.J., Skraban R., Lu Y., Chiavacci R.M., Stanley C.A., Kirsch S.E., Rappaport E.F., Orange J.S., Monos D.S., Devoto M., Qu H.Q., Polychronakos C. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448:591-594.
67. Hakonarson H., Qu H.Q., Bradfield J.P., Marchand L., Kim C.E., Glessner J.T., Grabs R., Casalunovo T., Taback S.P., Frackelton E.C., Eckert A.W., Annaiah K., Lawson M.L., Otieno F.G., Santa E., Shaner J.L., Smith R.M., Onyiah C.C., Skraban R., Chiavacci R.M., Robinson L.J., Stanley C.A., Kirsch S.E., Devoto M., Monos D.S., Grant S.F., Polychronakos C. A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes 2008, 57:1143-1146.
68. Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., Winter P.D. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991, 303:1019-1022.
69. Hani E.H., Boutin P., Durand E., Inoue H., Permutt M.A., Velho G., Froguel P. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 1998, 41:1511-1515.
70. Harder T., Roepke K., Diller N., Stechling Y., Dudenhausen J.W., Plagemann A. Birth weight, early weight gain, and subsequent risk of Type 1 diabetes: systematic review and meta-analysis. Am. J. Epidemiol. 2009, 169:1428-1436.
71. Hariharan M., Scaria V., Brahmachari S.K. DbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinf. 2009, 10:108.
72. Hashimoto L., Habita C., Beressi J.P., Delepine M., Besse C., Cambon-Thomsen A., Deschamps I., Rotter J.I., Djoulah S., James M.R., et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994, 371:161-164.
73. Hermann R., Knip M., Veijola R., Simell O., Laine A.P., Akerblom H.K., Groop P.H., Forsblom C., Pettersson-Fernholm K., Ilonen J. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes-indication of an increased environmental pressure?. Diabetologia 2003, 46:420-425.
74. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., del Bosque-Plata L., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., Bell G.I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 2000, 26:163-175.
75. Howson J.M., Walker N.M., Clayton D., Todd J.A. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes. Metab. 2009, 11(Suppl 1):31-45.
76. Howson J.M., Rosinger S., Smyth D.J., Boehm B.O., Todd J.A. Genetic analysis of adult-onset autoimmune diabetes. Diabetes 2011, 60:2645-2653.
77. Hviid A., Stellfeld M., Wohlfahrt J., Melbye M. Childhood vaccination and type 1 diabetes. N. Engl. J. Med. 2004, 350:1398-1404.
78. Hyppönen E. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association?. Diabetes Obes. Metab. 2010, 12:737-743.
79. International Diabetes Foundation, 2006. Diabetes Atlas, third ed. International Diabetes Foundation, Brussels.
80. Jia P., Zheng S., Long J., Zheng W., Zhao Z. DmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics 2011, 27:95-102.
81. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004, 32:D277-D280.
82. Kaprio J., Tuomilehto J., Koskenvuo M., Romanov K., Reunanen A., Eriksson J., Stengard J., Kesaniemi Y.A. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992, 35:1060-1067.
83. Knip M., Veijola R., Virtanen S.M., Hyöty H., Vaarala O., Åkerblom H.K. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005, 54:S125-S136.
84. Köbberling J., Tillil H. Empirical risk figures for first-degree relatives of non-insulin dependent diabetics. The Genetics of Diabetes Mellitus 1982, 201-209. Academic Press, London. J. Köbberling, R. Tattersall (Eds.).
85. Kong A., Steinthorsdottir V., Masson G., Thorleifsson G., Sulem P., Besenbacher S., Jonasdottir A., Sigurdsson A., Kristinsson K.T., Frigge M.L., Gylfason A., Olason P.I., Gudjonsson S.A., Sverrisson S., Stacey S.N., Sigurgeirsson B., Benediktsdottir K.R., Sigurdsson H., Jonsson T., Benediktsson R., Olafsson J.H., Johannsson O.T., Hreidarsson A.B., Sigurdsson G., Ferguson-Smith A.C., Gudbjartsson D.F., Thorsteinsdottir U., Stefansson K. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462:868-874.
86. Kyvik K.O., Green A., Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 1995, 311:913-917.
87. Lee I., Blom U.M., Wang P.I., Shim J.E., Marcotte E.M. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res. 2011, 21:1109-1121.
88. Liu L., Li Y., Tollefsbol T.O. Gene-environment interactions and epigenetic basis of human diseases. Curr. Issues Mol. Biol. 2008, 10:25-36.
89. Loos R.J., Lindgren C.M., Li S., Wheeler E., Zhao J.H., Prokopenko I., Inouye M., Freathy R.M., Attwood A.P., Beckmann J.S., Berndt S.I., Jacobs K.B., Chanock S.J., Hayes R.B., Bergmann S., Bennett A.J., Bingham S.A., Bochud M., Brown M., Cauchi S., Connell J.M., Cooper C., Smith G.D., Day I., Dina C., De S., Dermitzakis E.T., Doney A.S., Elliott K.S., Elliott P., Evans D.M., Sadaf Farooqi I., Froguel P., Ghori J., Groves C.J., Gwilliam R., Hadley D., Hall A.S., Hattersley A.T., Hebebrand J., Heid I.M., Lamina C., Gieger C., Illig T., Meitinger T., Wichmann H.E., Herrera B., Hinney A., Hunt S.E., Jarvelin M.R., Johnson T., Jolley J.D., Karpe F., Keniry A., Khaw K.T., Luben R.N., Mangino M., Marchini J., McArdle W.L., McGinnis R., Meyre D., Munroe P.B., Morris A.D., Ness A.R., Neville M.J., Nica A.C., Ong K.K., O'Rahilly S., Owen K.R., Palmer C.N., Papadakis K., Potter S., Pouta A., Qi L., Randall J.C., Rayner N.W., Ring S.M., Sandhu M.S., Scherag A., Sims M.A., Song K., Soranzo N., Speliotes E.K., Syddall H.E., Teichmann S.A., Timpson N.J., Tobias J.H., Uda M., Vogel C.I., Wallace C., Waterworth D.M., Weedon M.N., Willer C.J., Wraight, Yuan X., Zeggini E., Hirschhorn J.N., Strachan D.P., Ouwehand W.H., Caulfield M.J., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 2008, 40:768-775.
90. Lowe C.E., Cooper J.D., Brusko T., Walker N.M., Smyth D.J., Bailey R., Bourget K., Plagnol V., Field S., Atkinson M., Clayton D.G., Wicker L.S., Todd J.A. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat. Genet. 2007, 39:1074-1082.
91. Lupski J.R., Belmont J.W., Boerwinkle E., Gibbs R.A. Clan genomics and the complex architecture of human disease. Cell 2011, 147:32-43.
92. Lyssenko V., Jonsson A., Almgren P., Pulizzi N., Isomaa B., Tuomi T., Berglund G., Altshuler D., Nilsson P., Groop L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N. Engl. J. Med. 2008, 359:2220-2232.
93. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., Cho J.H., Guttmacher A.E., Kong A., Kruglyak L., Mardis E., Rotimi C.N., Slatkin M., Valle D., Whittemore A.S., Boehnke M., Clark A.G., Eichler E.E., Gibson G., Haines J.L., Mackay T.F., McCarroll S.A., Visscher P.M. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
94. Marchini J., Donnelly P., Cardon L.R. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat. Genet. 2005, 37:413-417.
95. Martin S., Wolf-Eichbaum D., Duinkerken G., Scherbaum W.A., Kolb H., Noordzij J.G., Roep B.O. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N. Engl. J. Med. 2001, 345:1036-1040.
96. Mein C.A., Esposito L., Dunn M.G., Johnson G.C., Timms A.E., Goy J.V., Smith A.N., Sebag-Montefiore L., Merriman M.E., Wilson A.J., Pritchard L.E., Cucca F., Barnett A.H., Bain S.C., Todd J.A. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat. Genet. 1998, 19:297-300.
97. Minton J.A., Hattersley A.T., Owen K., McCarthy M.I., Walker M., Latif F., Barrett T., Frayling T.M. Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes 2002, 51:1287-1290.
98. Moller A.M., Dalgaard L.T., Pociot F., Nerup J., Hansen T., Pedersen O. Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes. Diabetologia 1998, 41:1528-1531.
99. Moore J.H., Smolkin M.E., Lamb J.M., Brown N.J., Vaughan D.E. The relationship between plasma t-PA and PAI-1 levels is dependent on epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms. Clin. Genet. 2002, 62:53-59.
100. Morahan G., Mehta M., James I., Chen W.M., Akolkar B., Erlich H.A., Hilner J.E., Julier C., Nerup J., Nierras C., Pociot F., Todd J.A., Rich S.S. Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs. Diabetes 2011, 60:1030-1040.
101. Morris A.P., Voight B.F., Teslovich T.M., Ferreira T., Segre A.V., Steinthorsdottir V., Strawbridge R.J., Khan H., Grallert H., Mahajan A., Prokopenko I., Kang H.M., Dina C., Esko T., Fraser R.M., Kanoni S., Kumar A., Lagou V., Langenberg C., Luan J., Lindgren C.M., Muller-Nurasyid M., Pechlivanis S., Rayner N.W., Scott L.J., Wiltshire S., Yengo L., Kinnunen L., Rossin E.J., Raychaudhuri S., Johnson A.D., Dimas A.S., Loos R.J., Vedantam S., Chen H., Florez J.C., Fox C., Liu C.T., Rybin D., Couper D.J., Kao W.H., Li M., Cornelis M.C., Kraft P., Sun Q., van Dam R.M., Stringham H.M., Chines P.S., Fischer K., Fontanillas P., Holmen O.L., Hunt S.E., Jackson A.U., Kong A., Lawrence R., Meyer J., Perry J.R., Platou C.G., Potter S., Rehnberg E., Robertson N., Sivapalaratnam S., Stancakova A., Stirrups K., Thorleifsson G., Tikkanen E., Wood A.R., Almgren P., Atalay M., Benediktsson R., Bonnycastle L.L., Burtt N., Carey J., Charpentier G., Crenshaw A.T., Doney A.S., Dorkhan M., Edkins S., Emilsson V., Eury E., Forsen T., Gertow K., Gigante B., Grant G.B., Groves C.J., Guiducci C., Herder C., Hreidarsson A.B., Hui J., James A., Jonsson A., Rathmann W., Klopp N., Kravic J., Krjutskov K., Langford C., Leander K., Lindholm E., Lobbens S., Mannisto S., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 2012.
102. Murphy R., Ellard S., Hattersley A.T. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:200-213.
103. Musani S.K., Shriner D., Liu N., Feng R., Coffey C.S., Yi N., Tiwari H.K., Allison D.B. Detection of gene×gene interactions in genome-wide association studies of human population data. Hum. Hered. 2007, 63:67-84.
104. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., Gudjonsson J.E., Li Y., Tejasvi T., Feng B.J., Ruether A., Schreiber S., Weichenthal M., Gladman D., Rahman P., Schrodi S.J., Prahalad S., Guthery S.L., Fischer J., Liao W., Kwok P.Y., Menter A., Lathrop G.M., Wise C.A., Begovich A.B., Voorhees J.J., Elder J.T., Krueger G.G., Bowcock A.M., Abecasis G.R. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 2009, 41:199-204.
105. Neel J.V. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?. Am. J. Hum. Genet. 1962, 14:353-362.
106. Nejentsev S., Walker N., Riches D., Egholm M., Todd J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
107. Nerup J., Pociot F. A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am. J. Hum. Genet. 2001, 69:1301-1313.
108. Newman B., Selby J.V., King M.C., Slemenda C., Fabsitz R., Friedman G.D. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987, 30:763-768.
109. Nibbe R.K., Koyuturk M., Chance M.R. An integrative-omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput. Biol. 2010, 6:e1000639.
110. Patterson C.C., Dahlquist G.G., Gyürüs E., Green A., Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. The Lancet 2009, 373:2027-2033.
111. Pearson E.R., Flechtner I., Njolstad P.R., Malecki M.T., Flanagan S.E., Larkin B., Ashcroft F.M., Klimes I., Codner E., Iotova V., Slingerland A.S., Shield J., Robert J.J., Holst J.J., Clark P.M., Ellard S., Sovik O., Polak M., Hattersley A.T. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N. Engl. J. Med. 2006, 355:467-477.
112. Pescovitz M.D., Greenbaum C.J., Krause-Steinrauf H., Becker D.J., Gitelman S.E., Goland R., Gottlieb P.A., Marks J.B., McGee P.F., Moran A.M., Raskin P., Rodriguez H., Schatz D.A., Wherrett D., Wilson D.M., Lachin J.M., Skyler J.S. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N. Engl. J. Med. 2009, 361:2143-2152.
113. Petersen J.S., Marshall M.O., Baekkeskov S., Hejnaes K.R., Hoier-Madsen M., Dyrberg T. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Diabetologia 1993, 36:510-515.
114. Phillips P.C. Epistasis - the essential role of gene interactions in the structure and evolution of genetic systems. Nat. Rev. Genet. 2008, 9:855-867.
115. Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
116. Pociot F., Norgaard K., Hobolth N., Andersen O., Nerup J. A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark. Danish Study Group of Diabetes in Childhood. Diabetologia 1993, 36:870-875.
117. Pociot F., Akolkar B., Concannon P., Erlich H.A., Julier C., Morahan G., Nierras C.R., Todd J.A., Rich S.S., Nerup J. Genetics of type 1 diabetes: what's next?. Diabetes 2010, 59:1561-1571.
118. Prokopenko I., Langenberg C., Florez J.C., Saxena R., Soranzo N., Thorleifsson G., Loos R.J., Manning A.K., Jackson A.U., Aulchenko Y., Potter S.C., Erdos M.R., Sanna S., Hottenga J.J., Wheeler E., Kaakinen M., Lyssenko V., Chen W.M., Ahmadi K., Beckmann J.S., Bergman R.N., Bochud M., Bonnycastle L.L., Buchanan T.A., Cao A., Cervino A., Coin L., Collins F.S., Crisponi L., de Geus E.J., Dehghan A., Deloukas P., Doney A.S., Elliott P., Freimer N., Gateva V., Herder C., Hofman A., Hughes T.E., Hunt S., Illig T., Inouye M., Isomaa B., Johnson T., Kong A., Krestyaninova M., Kuusisto J., Laakso M., Lim N., Lindblad U., Lindgren C.M., McCann O.T., Mohlke K.L., Morris A.D., Naitza S., Orru M., Palmer C.N., Pouta A., Randall J., Rathmann W., Saramies J., Scheet P., Scott L.J., Scuteri A., Sharp S., Sijbrands E., Smit J.H., Song K., Steinthorsdottir V., Stringham H.M., Tuomi T., Tuomilehto J., Uitterlinden A.G., Voight B.F., Waterworth D., Wichmann H.E., Willemsen G., Witteman J.C., Yuan X., Zhao J.H., Zeggini E., Schlessinger D., Sandhu M., Boomsma D.I., Uda M., Spector T.D., Penninx B.W., Altshuler D., Vollenweider P., Jarvelin M.R., Lakatta E., Waeber G., Fox C.S., Peltonen L., Groop L.C., Mooser V., Cupples L.A., Thorsteinsdottir U., Boehnke M., Barroso I., et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 2009, 41:77-81.
119. Pujana M.A., Han J.D., Starita L.M., Stevens K.N., Tewari M., Ahn J.S., Rennert G., Moreno V., Kirchhoff T., Gold B., Assmann V., Elshamy W.M., Rual J.F., Levine D., Rozek L.S., Gelman R.S., Gunsalus K.C., Greenberg R.A., Sobhian B., Bertin N., Venkatesan K., Ayivi-Guedehoussou N., Sole X., Hernandez P., Lazaro C., Nathanson K.L., Weber B.L., Cusick M.E., Hill D.E., Offit K., Livingston D.M., Gruber S.B., Parvin J.D., Vidal M. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet. 2007, 39:1338-1349.
120. Qi L., Cornelis M.C., Kraft P., Stanya K.J., Linda Kao W.H., Pankow J.S., Dupuis J., Florez J.C., Fox C.S., Pare G., Sun Q., Girman C.J., Laurie C.C., Mirel D.B., Manolio T.A., Chasman D.I., Boerwinkle E., Ridker P.M., Hunter D.J., Meigs J.B., Lee C.H., Hu F.B., van Dam R.M. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum. Mol. Genet. 2010, 19:2706-2715.
121. Qu H.Q., Grant S.F., Bradfield J.P., Kim C., Frackelton E., Hakonarson H., Polychronakos C. Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies. J. Med. Genet. 2009, 46:553-554.
122. Raj S.M., Howson J.M., Walker N.M., Cooper J.D., Smyth D.J., Field S.F., Stevens H.E., Todd J.A. No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 2009, 52:2109-2116.
123. Renstrom F., Payne F., Nordstrom A., Brito E.C., Rolandsson O., Hallmans G., Barroso I., Nordstrom P., Franks P.W. Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum. Mol. Genet. 2009, 18:1489-1496.
124. Reynisdottir I., Thorleifsson G., Benediktsson R., Sigurdsson G., Emilsson V., Einarsdottir A.S., Hjorleifsdottir E.E., Orlygsdottir G.T., Bjornsdottir G.T., Saemundsdottir J., Halldorsson S., Hrafnkelsdottir S., Sigurjonsdottir S.B., Steinsdottir S., Martin M., Kochan J.P., Rhees B.K., Grant S.F., Frigge M.L., Kong A., Gudnason V., Stefansson K., Gulcher J.R. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet. 2003, 73:323-335.
125. Rossin E.J., Lage K., Raychaudhuri S., Xavier R.J., Tatar D., Benita Y., Cotsapas C., Daly M.J. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet. 2011, 7:e1001273.
126. Sandhu M.S., Weedon M.N., Fawcett K.A., Wasson J., Debenham S.L., Daly A., Lango H., Frayling T.M., Neumann R.J., Sherva R., Blech I., Pharoah P.D., Palmer C.N., Kimber C., Tavendale R., Morris A.D., McCarthy M.I., Walker M., Hitman G., Glaser B., Permutt M.A., Hattersley A.T., Wareham N.J., Barroso I. Common variants in WFS1 confer risk of type 2 diabetes. Nat. Genet. 2007, 39:951-953.
127. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., Daly M.J., Hughes T.E., Groop L., Altshuler D., Almgren P., Florez J.C., Meyer J., Ardlie K., Bengtsson Bostrom K., Isomaa B., Lettre G., Lindblad U., Lyon H.N., Melander O., Newton-Cheh C., Nilsson P., Orho-Melander M., Rastam L., Speliotes E.K., Taskinen M.R., Tuomi T., Guiducci C., Berglund A., Carlson J., Gianniny L., Hackett R., Hall L., Holmkvist J., Laurila E., Sjogren M., Sterner M., Surti A., Svensson M., Tewhey R., Blumenstiel B., Parkin M., Defelice M., Barry R., Brodeur W., Camarata J., Chia N., Fava M., Gibbons J., Handsaker B., Healy C., Nguyen K., Gates C., Sougnez C., Gage D., Nizzari M., Gabriel S.B., Chirn G.W., Ma Q., Parikh H., Richardson D., Ricke D., Purcell S. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
128. Schadt E.E., Bjorkegren J.L. NEW: network-enabled wisdom in biology, medicine, and health care. Sci. Transl. Med. 2012, 4:115rv1.
129. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., Prokunina-Olsson L., Ding C.J., Swift A.J., Narisu N., Hu T., Pruim R., Xiao R., Li X.Y., Conneely K.N., Riebow N.L., Sprau A.G., Tong M., White P.P., Hetrick K.N., Barnhart M.W., Bark C.W., Goldstein J.L., Watkins L., Xiang F., Saramies J., Buchanan T.A., Watanabe R.M., Valle T.T., Kinnunen L., Abecasis G.R., Pugh E.W., Doheny K.F., Bergman R.N., Tuomilehto J., Collins F.S., Boehnke M. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
130. Senee V., Chelala C., Duchatelet S., Feng D., Blanc H., Cossec J.C., Charon C., Nicolino M., Boileau P., Cavener D.R., Bougneres P., Taha D., Julier C. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat. Genet. 2006, 38:682-687.
131. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., Boutin P., Vincent D., Belisle A., Hadjadj S., Balkau B., Heude B., Charpentier G., Hudson T.J., Montpetit A., Pshezhetsky A.V., Prentki M., Posner B.I., Balding D.J., Meyre D., Polychronakos C., Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
132. Small K.S., Hedman A.K., Grundberg E., Nica A.C., Thorleifsson G., Kong A., Thorsteindottir U., Shin S.Y., Richards H.B., Soranzo N., Ahmadi K.R., Lindgren C.M., Stefansson K., Dermitzakis E.T., Deloukas P., Spector T.D., McCarthy M.I. Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat. Genet. 2011, 43:561-564.
133. Söderström U., Åman J., Hjern A. Being born in Sweden increases the risk for type 1 diabetes - a study of migration of children to Sweden as a natural experiment. Acta Paediatr. 2012, 101:73-77.
134. Song Y., Niu T., Manson J.E., Kwiatkowski D.J., Liu S. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am. J. Hum. Genet. 2004, 74:208-222.
135. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G.B., Styrkarsdottir U., Gretarsdottir S., Emilsson V., Ghosh S., Baker A., Snorradottir S., Bjarnason H., Ng M.C., Hansen T., Bagger Y., Wilensky R.L., Reilly M.P., Adeyemo A., Chen Y., Zhou J., Gudnason V., Chen G., Huang H., Lashley K., Doumatey A., So W.Y., Ma R.C., Andersen G., Borch-Johnsen K., Jorgensen T., van Vliet-Ostaptchouk J.V., Hofker M.H., Wijmenga C., Christiansen C., Rader D.J., Rotimi C., Gurney M., Chan J.C., Pedersen O., Sigurdsson G., Gulcher J.R., Thorsteinsdottir U., Kong A., Stefansson K. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 2007, 39:770-775.
136. Suhre K., Shin S.Y., Petersen A.K., Mohney R.P., Meredith D., Wagele B., Altmaier E., Deloukas P., Erdmann J., Grundberg E., Hammond C.J., de Angelis M.H., Kastenmuller G., Kottgen A., Kronenberg F., Mangino M., Meisinger C., Meitinger T., Mewes H.W., Milburn M.V., Prehn C., Raffler J., Ried J.S., Romisch-Margl W., Samani N.J., Small K.S., Wichmann H.E., Zhai G., Illig T., Spector T.D., Adamski J., Soranzo N., Gieger C. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011, 477:54-60.
137. Svensson J., Lyngaae-Jorgensen A., Carstensen B., Simonsen L.B., Mortensen H.B. Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr. Diabetes 2009, 10:248-254.
138. Taneera J., Lang S., Sharma A., Fadista J., Zhou Y., Ahlqvist E., Jonsson A., Lyssenko V., Vikman P., Hansson O., Parikh H., Korsgren O., Soni A., Krus U., Zhang E., Jing X.J., Esguerra J.L., Wollheim C.B., Salehi A., Rosengren A., Renstrom E., Groop L. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012, 16:122-134.
139. Tattersall R.B. Mild familial diabetes with dominant inheritance. Q. J. Med. 1974, 43:339-357.
140. Temple I.K., Shield J.P. Transient neonatal diabetes, a disorder of imprinting. J. Med. Genet. 2002, 39:872-875.
141. The Wellcome Trust Case Control Consortium, 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
142. Thorleifsson G., Walters G.B., Gudbjartsson D.F., Steinthorsdottir V., Sulem P., Helgadottir A., Styrkarsdottir U., Gretarsdottir S., Thorlacius S., Jonsdottir I., Jonsdottir T., Olafsdottir E.J., Olafsdottir G.H., Jonsson T., Jonsson F., Borch-Johnsen K., Hansen T., Andersen G., Jorgensen T., Lauritzen T., Aben K.K., Verbeek A.L., Roeleveld N., Kampman E., Yanek L.R., Becker L.C., Tryggvadottir L., Rafnar T., Becker D.M., Gulcher J., Kiemeney L.A., Pedersen O., Kong A., Thorsteinsdottir U., Stefansson K. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 2009, 41:18-24.
143. Thorn L.M., Forsblom C., Fagerudd J., Thomas M.C., Pettersson-Fernholm K., Saraheimo M., Waden J., Ronnback M., Rosengard-Barlund M., Bjorkesten C.G., Taskinen M.R., Groop P.H. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005, 28:2019-2024.
144. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., Bailey R., Nejentsev S., Field S.F., Payne F., Lowe C.E., Szeszko J.S., Hafler J.P., Zeitels L., Yang J.H., Vella A., Nutland S., Stevens H.E., Schuilenburg H., Coleman G., Maisuria M., Meadows W., Smink L.J., Healy B., Burren O.S., Lam A.A., Ovington N.R., Allen J., Adlem E., Leung H.T., Wallace C., Howson J.M., Guja C., Ionescu-Tirgoviste C., Simmonds M.J., Heward J.M., Gough S.C., Dunger D.B., Wicker L.S., Clayton D.G. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007, 39:857-864.
145. Tong Y., Lin Y., Zhang Y., Yang J., Liu H., Zhang B. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med. Genet. 2009, 10:15.
146. Tonjes A., Scholz M., Loeffler M., Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 2006, 29:2489-2497.
147. Tsai F.J., Yang C.F., Chen C.C., Chuang L.M., Lu C.H., Chang C.T., Wang T.Y., Chen R.H., Shiu C.F., Liu Y.M., Chang C.C., Chen P., Chen C.H., Fann C.S., Chen Y.T., Wu J.Y. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2010, 6:e1000847.
148. Tuomi T., Groop L.C., Zimmet P.Z., Rowley M.J., Knowles W., Mackay I.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993, 42:359-362.
149. Tuomi T., Carlsson A., Li H., Isomaa B., Miettinen A., Nilsson A., Nissen M., Ehrnstrom B.O., Forsen B., Snickars B., Lahti K., Forsblom C., Saloranta C., Taskinen M.R., Groop L.C. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999, 48:150-157.
150. Unoki H., Takahashi A., Kawaguchi T., Hara K., Horikoshi M., Andersen G., Ng D.P., Holmkvist J., Borch-Johnsen K., Jorgensen T., Sandbaek A., Lauritzen T., Hansen T., Nurbaya S., Tsunoda T., Kubo M., Babazono T., Hirose H., Hayashi M., Iwamoto Y., Kashiwagi A., Kaku K., Kawamori R., Tai E.S., Pedersen O., Kamatani N., Kadowaki T., Kikkawa R., Nakamura Y., Maeda S. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 2008, 40:1098-1102.
151. Vaarala, O., 2005. In: Koletzko, B. et al. (Eds.), Is Type 1 Diabetes a Disease of the Gut Immune System Triggered by Cow's Milk Insulin? Early Nutrition and its Later Consequences: New Opportunities. Springer, Netherlands, pp. 151-156.
152. van den Ouweland J.M.W., Lemkes H.H.P.J., Ruitenbeek W., Sandkuijl L.A., de Vijlder M.F., Struyvenberg P.A.A., van de Kamp J.J.P., Maassen J.A. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1992, 1:368-371.
153. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., Zeggini E., Huth C., Aulchenko Y.S., Thorleifsson G., McCulloch L.J., Ferreira T., Grallert H., Amin N., Wu G., Willer C.J., Raychaudhuri S., McCarroll S.A., Langenberg C., Hofmann O.M., Dupuis J., Qi L., Segre A.V., van Hoek M., Navarro P., Ardlie K., Balkau B., Benediktsson R., Bennett A.J., Blagieva R., Boerwinkle E., Bonnycastle L.L., Bengtsson Bostrom K., Bravenboer B., Bumpstead S., Burtt N.P., Charpentier G., Chines P.S., Cornelis M., Couper D.J., Crawford G., Doney A.S., Elliott K.S., Elliott A.L., Erdos M.R., Fox C.S., Franklin C.S., Ganser M., Gieger C., Grarup N., Green T., Griffin S., Groves C.J., Guiducci C., Hadjadj S., Hassanali N., Herder C., Isomaa B., Jackson A.U., Johnson P.R., Jorgensen T., Kao W.H., Klopp N., Kong A., Kraft P., Kuusisto J., Lauritzen T., Li M., Lieverse A., Lindgren C.M., Lyssenko V., Marre M., Meitinger T., Midthjell K., Morken M.A., Narisu N., Nilsson P., Owen K.R., Payne F., Perry J.R., Petersen A.K., Platou C., Proenca C., Prokopenko I., Rathmann W., Rayner N.W., Robertson N.R., Rocheleau G., Roden M., Sampson M.J., Saxena R., Shields B.M., Shrader P., Sigurdsson G., Sparso T., Strassburger K., Stringham H.M., Sun Q., Swift A.J., Thorand B., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589.
154. Wallace C., Smyth D.J., Maisuria-Armer M., Walker N.M., Todd J.A., Clayton D.G. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat. Genet. 2010, 42:68-71.
155. Weedon M.N., Schwarz P.E., Horikawa Y., Iwasaki N., Illig T., Holle R., Rathmann W., Selisko T., Schulze J., Owen K.R., Evans J., Del Bosque-Plata L., Hitman G., Walker M., Levy J.C., Sampson M., Bell G.I., McCarthy M.I., Hattersley A.T., Frayling T.M. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am. J. Hum. Genet. 2003, 73:1208-1212.
156. Willer C.J., Speliotes E.K., Loos R.J., Li S., Lindgren C.M., Heid I.M., Berndt S.I., Elliott A.L., Jackson A.U., Lamina C., Lettre G., Lim N., Lyon H.N., McCarroll S.A., Papadakis K., Qi L., Randall J.C., Roccasecca R.M., Sanna S., Scheet P., Weedon M.N., Wheeler E., Zhao J.H., Jacobs L.C., Prokopenko I., Soranzo N., Tanaka T., Timpson N.J., Almgren P., Bennett A., Bergman R.N., Bingham S.A., Bonnycastle L.L., Brown M., Burtt N.P., Chines P., Coin L., Collins F.S., Connell J.M., Cooper C., Smith G.D., Dennison E.M., Deodhar P., Elliott P., Erdos M.R., Estrada K., Evans D.M., Gianniny L., Gieger C., Gillson C.J., Guiducci C., Hackett R., Hadley D., Hall A.S., Havulinna A.S., Hebebrand J., Hofman A., Isomaa B., Jacobs K.B., Johnson T., Jousilahti P., Jovanovic Z., Khaw K.T., Kraft P., Kuokkanen M., Kuusisto J., Laitinen J., Lakatta E.G., Luan J., Luben R.N., Mangino M., McArdle W.L., Meitinger T., Mulas A., Munroe P.B., Narisu N., Ness A.R., Northstone K., O'Rahilly S., Purmann C., Rees M.G., Ridderstrale M., Ring S.M., Rivadeneira F., Ruokonen A., Sandhu M.S., Saramies J., Scott L.J., Scuteri A., Silander K., Sims M.A., Song K., Stephens J., Stevens S., Stringham H.M., Tung Y.C., Valle T.T., Van Duijn C.M., Vimaleswaran K.S., Vollenweider P., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 2009, 41:25-34.
157. Winckler W., Graham R.R., de Bakker P.I., Sun M., Almgren P., Tuomi T., Gaudet D., Hudson T.J., Ardlie K.G., Daly M.J., Hirschhorn J.N., Groop L., Altshuler D. Association testing of variants in the hepatocyte nuclear factor 4alpha gene with risk of type 2 diabetes in 7,883 people. Diabetes 2005, 54:886-892.
158. Wong F.S., Wen L., Tang M., Ramanathan M., Visintin I., Daugherty J., Hannum L.G., Janeway C.A., Shlomchik M.J. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 2004, 53:2581-2587.
159. Yamagata K., Oda N., Kaisaki P.J., Menzel S., Furuta H., Vaxillaire M., Southam L., Cox R.D., Lathrop G.M., Boriraj V.V., Chen X., Cox N.J., Oda Y., Yano H., Le Beau M.M., Yamada S., Nishigori H., Takeda J., Fajans S.S., Hattersley A.T., Iwasaki N., Hansen T., Pedersen O., Polonsky K.S., Bell G.I., et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384:455-458.
160. Yamagata K., Furuta H., Oda N., Kaisaki P.J., Menzel S., Cox N.J., Fajans S.S., Signorini S., Stoffel M., Bell G.I. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996, 384:458-460.
161. Yasuda K., Miyake K., Horikawa Y., Hara K., Osawa H., Furuta H., Hirota Y., Mori H., Jonsson A., Sato Y., Yamagata K., Hinokio Y., Wang H.Y., Tanahashi T., Nakamura N., Oka Y., Iwasaki N., Iwamoto Y., Yamada Y., Seino Y., Maegawa H., Kashiwagi A., Takeda J., Maeda E., Shin H.D., Cho Y.M., Park K.S., Lee H.K., Ng M.C., Ma R.C., So W.Y., Chan J.C., Lyssenko V., Tuomi T., Nilsson P., Groop L., Kamatani N., Sekine A., Nakamura Y., Yamamoto K., Yoshida T., Tokunaga K., Itakura M., Makino H., Nanjo K., Kadowaki T., Kasuga M. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 2008, 40:1092-1097.
162. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., Timpson N.J., Perry J.R., Rayner N.W., Freathy R.M., Barrett J.C., Shields B., Morris A.P., Ellard S., Groves C.J., Harries L.W., Marchini J.L., Owen K.R., Knight B., Cardon L.R., Walker M., Hitman G.A., Morris A.D., Doney A.S., McCarthy M.I., Hattersley A.T. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
163. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., de Bakker P.I., Abecasis G.R., Almgren P., Andersen G., Ardlie K., Bostrom K.B., Bergman R.N., Bonnycastle L.L., Borch-Johnsen K., Burtt N.P., Chen H., Chines P.S., Daly M.J., Deodhar P., Ding C.J., Doney A.S., Duren W.L., Elliott K.S., Erdos M.R., Frayling T.M., Freathy R.M., Gianniny L., Grallert H., Grarup N., Groves C.J., Guiducci C., Hansen T., Herder C., Hitman G.A., Hughes T.E., Isomaa B., Jackson A.U., Jorgensen T., Kong A., Kubalanza K., Kuruvilla F.G., Kuusisto J., Langenberg C., Lango H., Lauritzen T., Li Y., Lindgren C.M., Lyssenko V., Marvelle A.F., Meisinger C., Midthjell K., Mohlke K.L., Morken M.A., Morris A.D., Narisu N., Nilsson P., Owen K.R., Palmer C.N., Payne F., Perry J.R., Pettersen E., Platou C., Prokopenko I., Qi L., Qin L., Rayner N.W., Rees M., Roix J.J., Sandbaek A., Shields B., Sjogren M., Steinthorsdottir V., Stringham H.M., Swift A.J., Thorleifsson G., Thorsteinsdottir U., Timpson N.J., Tuomi T., Tuomilehto J., Walker M., Watanabe R.M., Weedon M.N., Willer C.J., Illig T., Hveem K., Hu F.B., Laakso M., Stefansson K., Pedersen O., Wareham N.J., Barroso I., Hattersley A.T., Collins F.S., Groop L., McCarthy M.I., Boehnke M., Altshuler D. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 2008, 40:638-645.
164. Zuk O., Hechter E., Sunyaev S.R., Lander E.S. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA 2012, 109:1193-1198.